Probiotic for during and post-antibiotic care
• Proven to supplement the normal intestinal microbiota following antibiotic therapy
• Provides 100 billion CFU per dose
HMF Antibiotic Care helps to supplement the normal intestinal microbiota following antibiotic therapy. The results of the Cambridge Probiotic/Antibiotic Trial demonstrate that strains included in this probiotic formula improved intestinal microflora response to the negative effects of antibiotic therapy, including preventing overgrowth of coliforms, enterococci and Staphylococcus aureus bacteria, preserving Lactobacillus bacteria populations, and reducing the level of antibiotic-resistant bacteria.
Supplement Facts:
EACH CAPSULE CONTAINS:
Probiotic Consortium . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 100 billion CFU
Lactobacillus acidophilus (CUL-60) . . . . . . . . . . . . . . . . . . . . . 25 billion CFU Lactobacillus acidophilus (CUL-21) . . . . . . . . . . . . . . . . . . . . . 25 billion CFU Lactobacillus salivarius (CUL-61) . . . . . . . . . . . . . . . . . . . . . . . 25 billion CFU Bifidobacterium animalis subsp. lactis (CUL-34) . . . . . . . . . . . 23.75 billion CFU Bifidobacterium bifidum (CUL-20) . . . . . . . . . . . . . . . . . . . . . . . 1.25 billion CFU
Non-medicinal ingredients: Fructooligosaccharides (FOS), hypromellose, silica, magnesium stearate